Herpes Zoster Market Highlights:

Herpes Zoster Market size report has valued the industry size at USD 0.15 billion in 2022 and is projected to grow from USD 0.16 Billion in 2023 to USD 0.27 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.90% during the forecast period (2023 - 2030).

The Herpes Zoster Market is undergoing a dramatic shift, driven by a mix of variables such as an ageing population, increased vaccine knowledge, and advances in antiviral medicines. The dynamic breadth of this industry extends beyond treatment to include prevention via vaccinations and novel techniques.

However, obstacles such as vaccine hesitancy and a lack of efficient antiviral drugs might stymie progress. Nonetheless, the Herpes Zoster Market is a sentinel against the painful shingles virus, with a steadfast dedication to education, mass vaccination campaigns, and the discovery of breakthrough medicines. In an era when healthcare prioritises prevention over treatment, it holds the promise of not only managing but also reducing the occurrence of Herpes Zoster, paving the way for a future in which fewer people suffer from its terrible effects.

Segmentation:

The global herpes zoster market is segmented into Diagnosis, application, end-users. The herpes zoster market, by Diagnosis, the market is segmented into laboratory testing and others. The laboratory testing segment is further categorized into immunofluorescent microscopy, real-time Polymerase Chain Reaction (PCR), serological testing. The treatment and prevention segment for the global herpes zoster market is divided into antiviral medications, narcotic medications, anti-inflammatory medications, antihistamines, anticonvulsants, capsaicin, numbing creams, gels, or patches, vaccines, and others. The route of administration segment for the global herpes zoster market is divided into oral, topical, and others. The end-user segment for the global herpes zoster market is divided into hospitals & clinics, diagnostic centers, research & academic institutes, home care settings, and others.

Regional Analysis:

The Americas is the largest in the market owing to the increasing government support for vaccination and the highly advanced healthcare facilities to address the growing incidence of the infection. The number of Americans aged 65 or above are projected to be doubled from 46 million to 98 million by 2060, with the subsequent rise in the older age group to nearly 24 percent of the total population from the present 15 percent. The disease is prevalent in older adults usually between 60 -80 years due to the weak immune system thereby providing an opportunity for future growth of the market.

European region is the second largest market over the forecast period due to factors such as the emerging innovative vaccines for disease management and rising incidence of herpes zoster will provide considerable growth opportunities to herpes zoster treatment companies in the European region. The growing prevalence of the herpes zoster infection in the regions such as Asia Pacific and Middle East & Africa which will emerge as the fastest growing regions in the global herpes zoster infection treatment market.

Key Players:

Some of the key players in the herpes zoster market outlook report are Astellas Pharma Inc. (Japan), Foamix Pharmaceuticals (Israel), Geneone Life Science (South Korea), GlaxoSmithKline plc (UK), Merck & Co. Inc. (US), NAL Pharma (Hong Kong), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd. (Switzerland), TSRL, Inc. and others.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com